STTK Latest Press Releases

-- October 13, 2026 --

Shattuck Labs Announces Two Poster Presentations at UEG Week 2026 Globe Newswire 8:00 AM

-- October 1, 2026 --

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development Globe Newswire 7:00 AM

-- September 2, 2026 --

Shattuck Labs Announces Participation in Upcoming September Investor Conferences Globe Newswire 4:05 PM

-- August 11, 2026 --

Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights Globe Newswire 6:15 AM

-- June 10, 2026 --

Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering Globe Newswire 12:21 AM

-- June 9, 2026 --

Shattuck Labs, Inc. Announces Proposed Public Offering Globe Newswire 4:18 PM

Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update Globe Newswire 8:00 AM

-- June 8, 2026 --

Shattuck Labs Announces Phase 1 Results for SL-325 Globe Newswire 6:00 AM

-- June 5, 2026 --

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8 Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes